Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases

Background: In the last years, inflammatory bowel disease (IBD) and hepatitis C virus (HCV) infection management has completely changed. However, the role of direct-acting antivirals (DAAs) and the correct timing of antiviral drugs administration in IBD patients needing biologics has not been evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Imperatore, Nicola, Castiglione, Fabiana, Rispo, Antonio, Sessa, Anna, Caporaso, Nicola, Morisco, Filomena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702483/
https://www.ncbi.nlm.nih.gov/pubmed/29209223
http://dx.doi.org/10.3389/fphar.2017.00867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702483/
https://www.ncbi.nlm.nih.gov/pubmed/29209223
http://dx.doi.org/10.3389/fphar.2017.00867

Ejemplares similares